Melatonin, the pineal gland hormone, has been shown to play a principle role in maintenance of health and well being of man and animals in all stages of life. The aim of the present study was to investigate the effect of melatonin on some hematological parameters and immune status of broiler chicks. For this purpose sixty-four, three weeks-old chicks of Hubbard strain weighing 500-633g were used. Birds were kept on lighting regimen of 12 hours natural light to 12 hours darkness. Chicks were randomly allocated into four equal groups of 16 birds each. The first group was kept as a control group and fed starter ration sprayed with ethanol saline without melatonin from the 4 th to 8 th weeks of age. The second, third and fourth groups were fed on the starter ration sprayed with ethanol saline containing 20, 30 and 40 mg melatonin / kg ration, respectively from the 4 th to 8 th weeks of age. Blood samples were obtained from the tibial vein of all birds at the end of the 1 st week of treatment and then every week up to the end of the experiment. The obtained blood were used for determination of red blood cells (RBCs) count, hemoglobin (Hb) concentration, packed cell volume (PCV) as well as total and differential leukocytic count. Tissue samples from liver, spleen, thymus and bursa of Fabricious were taken for histopathological examination. The results revealed that melatonin in the three doses produced a significant increase in RBCs count, PCV, Hb concentration, total leukocytic count and lymphocyte percentage which clarifies the effect of melatonin on improving the health and immune status of the chicks under investigation. The histopathological study in the present investigation revealed that melatonin treatment induced a lymphoid hyperplasia in the liver, spleen, and bursa of Fabricious of all treated groups. This lymphoid hyperplasia might be another explanations for the immunostimulant effect of melatonin. In conclusion melatonin was found to improve the health and immune status of broiler chicks.
Aim: Oxidative stress (OS) is one of the major disruptors of oocyte developmental competence, which appears due to the imbalance between the production and neutralization of reactive oxygen species (ROS).
Materials and Methods: In Experiment 1, buffalo oocytes were in vitro matured, fertilized, and cultured at 38.5°C under 5% CO2 + 20% O2 in standard CO2 incubator (OS) or under 5% O2 + 5% CO2 + 90% N2 (Multi-gas incubator, low O2). In Experiment 2, buffalo cumulus oocytes complexes (COCs) were matured in Basic maturation medium (BMM) composed of TCM199+ 10% FCS+ 10 μg/ml FSH+ 50 μg/ml gentamicin (control group) or in BMM supplemented with 50 μM ascorbic acid (ascorbic acid group) or 3.0 mM glutathione (glutathione group) or 10-5 M melatonin (melatonin group) and cultured at 38.5°C under 20% O2 for 24 h. Matured buffalo oocytes in control, ascorbic acid, or melatonin groups were fertilized and zygotes were cultured for 8 days under the same conditions.
Results: In both experiments, maturation, cleavage, and blastocyst rates were recorded. Results showed that culture of buffalo oocytes under low O2 (5% O2) significantly increased maturation, cleavage, and blastocyst rates (p<0.05). Meanwhile, under 20% O2, addition of 10-5 M melatonin or 50 μM ascorbic acid to in vitro maturation (IVM) medium significantly improved cumulus cell expansion, nuclear maturation rates of buffalo oocytes (p<0.05), and increased cleavage and blastocyst rates (p<0.05).
Conclusion: About 5% O2 is the optimum condition for in vitro production of buffalo embryos, and addition of 10-5 M melatonin to IVM medium for oocytes cultured under 20% O2 could alleviate the adverse effect of high oxygen tension and increased embryo yield.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.